Skip to content

Clinical trials

Phase 2/3 Brain Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Phase: Phase 2/3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20142
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Terminated2
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Melbourne2
AstraZeneca1
Mediforum Ltd., Co.1
University of California, San Diego1
University of Oxford1
University of Southern California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases7
Central Nervous System Diseases5
Cerebrovascular Disorders4
Nervous System Diseases4
Alzheimer Disease3
Dementia3
Stroke3
Cardiovascular Diseases2
Cerebral Infarction2
Ischemic Stroke2

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.